These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15599801)

  • 1. Modern Drug Discovery and Development. 18-19 October 2004, San Diego, CA, USA.
    Xu J
    IDrugs; 2004 Dec; 7(12):1090-3. PubMed ID: 15599801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery 99: accelerate and improve the drug discovery process. 26-29 April 1999, San Diego, CA, USA.
    Young SS
    IDrugs; 1999 Jul; 2(7):648-9. PubMed ID: 16127631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHI's Fourth Annual Drug Discovery Chemistry Conference. Kinase inhibitor chemistry: charting the chemical space. 7-8 April 2009, San Diego, CA, USA.
    Seneci P
    IDrugs; 2009 Jun; 12(6):358-62. PubMed ID: 19517315
    [No Abstract]   [Full Text] [Related]  

  • 4. Is there a best strategy for drug discovery?
    Warne P; Page C
    Drug News Perspect; 2003 Apr; 16(3):177-82. PubMed ID: 12819816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug discovery, drug development and the emerging world of pharmacogenomics: prospecting for information in a data-rich landscape.
    Michelson S; Joho K
    Curr Opin Mol Ther; 2000 Dec; 2(6):651-4. PubMed ID: 11249742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality by design (QbD) approach of pharmacogenomics in drug designing and formulation development for optimization of drug delivery systems.
    Gupta S; Jhawat V
    J Control Release; 2017 Jan; 245():15-26. PubMed ID: 27871989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinatorial chemistry as a new approach in antiparasitic drug discovery.
    Link A
    Parasitol Res; 2003 Jun; 90 Suppl 2():S86-90. PubMed ID: 12734752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highlights from SelectBio 2015: Academic Drug Discovery Conference, Cambridge, UK, 19-20 May 2015.
    Spencer J; Coaker H
    Future Med Chem; 2015; 7(14):1839-42. PubMed ID: 26420379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies and techniques for identification of novel bioactive compounds--CHI's second annual conference. 7-9 October 1998, Zurich, Switzerland.
    Kubinyi H
    IDrugs; 1998 Dec; 1(8):883-6. PubMed ID: 16196479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cambridge Healthtech Institute fourth annual conference in structure-based drug design.
    McInnes C
    IDrugs; 2004 Jun; 7(6):543-7. PubMed ID: 15197656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragment-Based Drug Discovery--CHI's Fourth Annual Meeting. 6-7 April 2009, San Diego, CA, USA.
    Seneci P
    IDrugs; 2009 Jun; 12(6):353-7. PubMed ID: 19517314
    [No Abstract]   [Full Text] [Related]  

  • 13. Conference report: hot topics in antibody-drug conjugate development.
    Thudium K; Bilic S
    Bioanalysis; 2013 Dec; 5(24):2989-93. PubMed ID: 24320125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based approaches to antibiotic drug discovery.
    Nicola G; Abagyan R
    Curr Protoc Microbiol; 2009 Feb; Chapter 17():Unit17.2. PubMed ID: 19235149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Diseases Drug Discovery World Summit.
    Liu G
    Expert Opin Emerg Drugs; 2003 Nov; 8(2):577-82. PubMed ID: 14662006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hit and lead generation: beyond high-throughput screening.
    Bleicher KH; Böhm HJ; Müller K; Alanine AI
    Nat Rev Drug Discov; 2003 May; 2(5):369-78. PubMed ID: 12750740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Institutional Profile: University of California San Diego Pharmacogenomics Education Program (PharmGenEd™): bridging the gap between science and practice.
    Kuo GM; Ma JD; Lee KC; Halpert JR; Bourne PE; Ganiats TG; Taylor P
    Pharmacogenomics; 2011 Feb; 12(2):149-53. PubMed ID: 21332308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in pharmacogenomics and its promise for medicine.
    Blake CA; Sobel BE
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1482-3. PubMed ID: 18849537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging chemical and biological approaches for the preparation of discovery libraries.
    Boldt GE; Dickerson TJ; Janda KD
    Drug Discov Today; 2006 Feb; 11(3-4):143-8. PubMed ID: 16533712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical genomics as an emerging paradigm for postgenomic drug discovery.
    Salemme FR
    Pharmacogenomics; 2003 May; 4(3):257-67. PubMed ID: 12718717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.